United Therapeutics (UTHR)

Add to Watchlists
Create an Alert
126.20 +3.18  +2.58% NASDAQ Nov 20, 20:00 Delayed 2m USD

United Therapeutics Revenue (TTM):

1.670B for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

United Therapeutics Revenue (TTM) Chart

Export Data
Save Image
Print Image

United Therapeutics Historical Revenue (TTM) Data

View and export this data going back to 1999. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 1.670B
June 30, 2017 1.632B
March 31, 2017 1.600B
Dec. 31, 2016 1.599B
Sept. 30, 2016 1.595B
June 30, 2016 1.573B
March 31, 2016 1.507B
Dec. 31, 2015 1.466B
Sept. 30, 2015 1.407B
June 30, 2015 1.351B
March 31, 2015 1.327B
Dec. 31, 2014 1.288B
Sept. 30, 2014 1.231B
June 30, 2014 1.203B
March 31, 2014 1.161B
Dec. 31, 2013 1.117B
Sept. 30, 2013 1.072B
June 30, 2013 1.012B
March 31, 2013 957.00M
Dec. 31, 2012 916.08M
Sept. 30, 2012 867.44M
June 30, 2012 826.71M
March 31, 2012 784.88M
Dec. 31, 2011 743.18M
Sept. 30, 2011 711.70M
   
June 30, 2011 678.53M
March 31, 2011 629.50M
Dec. 31, 2010 595.87M
Sept. 30, 2010 541.10M
June 30, 2010 469.74M
March 31, 2010 419.00M
Dec. 31, 2009 369.85M
Sept. 30, 2009 336.79M
June 30, 2009 314.60M
March 31, 2009 299.18M
Dec. 31, 2008 281.50M
Sept. 30, 2008 265.53M
June 30, 2008 249.55M
March 31, 2008 232.82M
Dec. 31, 2007 210.94M
Sept. 30, 2007 196.87M
June 30, 2007 178.22M
March 31, 2007 166.64M
Dec. 31, 2006 159.63M
Sept. 30, 2006 143.45M
June 30, 2006 136.06M
March 31, 2006 125.87M
Dec. 31, 2005 115.92M
Sept. 30, 2005 107.89M
June 30, 2005 94.87M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

UTHR Revenue (TTM) Benchmarks

Companies
Ligand Pharmaceuticals 128.82M
Ionis Pharmaceuticals 495.72M
Natus Medical 477.23M

UTHR Revenue (TTM) Range, Past 5 Years

Minimum 916.08M Dec 2012
Maximum 1.670B Sep 2017
Average 1.334B

UTHR Revenue (TTM) Excel Add-In Codes

  • Metric Code: revenues_ttm
  • Latest data point: =YCP("UTHR", "revenues_ttm")
  • Last 5 data points: =YCS("UTHR", "revenues_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.